ELIZABETH O'LEARY: Open Payments
NPI 1639115553 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,553 in 72 payments from 19 companies in 2025. Trend: 2023 $2,977 · 2024 $1,268 · 2025 $1,553
Food & beverage: $1,553
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $275 |
| Ardelyx, Inc. | 12 | $224 |
| Fresenius USA Marketing, Inc. | 7 | $159 |
| Otsuka America Pharmaceutical, Inc. | 4 | $117 |
| Novo Nordisk Inc | 4 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $107 |
| Calliditas Therapeutics US Inc. | 4 | $93 |
| Apellis Pharmaceuticals, Inc. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
Products named: IBSRELA, KRYSTEXXA, VELPHORO, JYNARQUE, Kerendia, JARDIANCE, TARPEYO, TAVNEOS.
Industry payments across NC — which companies pay providers there.
